603387 基蛋生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.7348.2168.63711.09821.744
总资产报酬率 ROA (%)2.0475.9135.9807.51014.638
投入资产回报率 ROIC (%)2.3136.7266.8238.65316.945

边际利润分析
销售毛利率 (%)70.34369.79069.22966.36965.069
营业利润率 (%)30.35621.96622.15422.39230.916
息税前利润/营业总收入 (%)29.25320.36118.72318.59428.996
净利润/营业总收入 (%)27.37920.15019.73520.74827.661

收益指标分析
经营活动净收益/利润总额(%)93.063111.692108.32494.241101.445
价值变动净收益/利润总额(%)5.5548.0340.3858.4386.164
营业外收支净额/利润总额(%)-0.388-1.462-1.823-0.540-0.585

偿债能力分析
流动比率 (X)3.2092.6931.9762.1962.504
速动比率 (X)2.9382.4781.7691.9622.223
资产负债率 (%)20.70023.87026.60727.31927.571
带息债务/全部投入资本 (%)12.90015.29118.31120.71320.110
股东权益/带息债务 (%)665.017545.794438.350375.312388.934
股东权益/负债合计 (%)369.552307.036265.502248.386244.750
利息保障倍数 (X)-29.701-15.804-6.170-5.055-16.660

营运能力分析
应收账款周转天数 (天)115.294122.455123.749123.43192.161
存货周转天数 (天)215.379214.307213.013195.100147.557